Fig. 3
From: Progress in preventive therapy for cancer: a reminiscence and personal viewpoint
Reduced risk of contralateral breast cancer in trials comparing an aromatase inhibitor to tamoxifen. (Reprinted with permission from ref.20)
Fig. 3 | British Journal of Cancer
